Quantifi helps global banks with market-leading pricing and risk management tools that integrate easily with existing processes and scale to support the largest portfolios.

Five of the six largest global investment banks have licensed Quantifi products.

In an environment where global banks are faced with intense regulatory and public scrutiny - comprehensive risk management and operational transparency are essential. Quantifi provides global banks with advanced risk management solutions that integrate with existing workflows to deliver consistent front to back-office valuations.

Comprehensive and independent risk management are key elements of any solution that addresses regulatory and corporate governance requirements. Quantifi’s suite of risk management tools perform market and counterparty risk analyses based on independent market-validated models.

As business evolves and needs change, the ability to rapidly scale up or down is crucial. Global banks rely on Quantifi to provide leverage for internal resources, allowing flexible and rapid scaling of business lines without costly reallocation of internal resources.

To maintain a competitive advantage, global banks need sophisticated risk management solutions, designed to offer fast, accurate and timely results. Quantifi’s solutions are easy to implement, seamlessly integrate with other proprietary or 3^rd party systems and deliver high performance without sacrificing precision.

Increased market risks and new regulatory initiatives have driven a focus on counterparty risk measurement and management. Counterparty risk affects all aspects of OTC trading – including front office pricing, accounting, credit risk management and regulatory reporting. Quantifi provides integrated counterparty risk solutions that address both front-office pricing and risk reporting requirements.

Quantifi helps Global Banks to:

• More efficiently and effectively trade, value, and risk manage an OTC business
• Rapidly deploy a turn-key solution for a growing or new business
• Price CVA for front office trading of OTC derivatives
• Actively manage and trade counterparty credit exposures
• Perform cross-asset portfolio counterparty risk management
• Report counterparty risk for Basel II and III compliance
• Provide ASC 820 (FAS 157) and IAS 39 compliance
• Facilitate client connectivity with pre-trade analysis of OTC derivatives
• Reduce the support cost for a runoff business
• Independently value an OTC derivatives portfolio
• Validate internal models